- $2.25bn
- $3.13bn
- $2.72bn
Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Brief: Fortrea Completes Acquisition Of The Early Phase Services Division From Worldwide Clinical Trials
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike
Brief: Fortrea Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Brief: Fortrea - Reinstates Jason Knoblauch As CFO On September 9, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Fortrea gains after $45 million deal for Worldwide Clinical Trials' early-stage services business
Fortrea Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Fortrea Q2 revenue beats expectations, outlook raised
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
TD Cowen sees improving demand for contract research firms in Q2 2026
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber